Document is current
Any future updates will be listed below
-
Authors
Blanc, Frédéric https://orcid.org/0000-0002-6714-3247
Cretin, Benjamin
Muller, Candice
Botzung, Anne
Sanna, Lea
Bousiges, Olivier
Ravier, Alix
Schorr, Benoît
Anthony, Pierre
Philippi, Nathalie
Demuynck, Catherine
Sauleau, Erik
-
Funding
Funding for this research was provided by:
PHRC (IDRCB 2012-A00992-41)
Fondation Université de Strasbourg
France Alzheimer
Hôpitaux Universitaires de Strasbourg (Appel à projet interne)
- License Information
-
More Information
Article History
Received: 29 December 2023
Accepted: 20 October 2025
First Online: 18 November 2025
Declarations
:
: F.B. was the national coordinator for France for the Eisai Delphia (E2027), Axovant Headway-DLB and Roche Graduate therapeutic trials; he had received honoraria from Roche, Eisai and Biogen for oral presentations and from Eisai and Novo Nordisk for a board. The other authors declare that they have no competing interests related to the present work.
